Marcos Ferrante

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Heat Shock Protein

Cardiac Surgery

Top Venues

Pharmaceuticals (Basel, Switzerland)

Veterinary sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Marcos Ferrante, Bruna Martins Macedo Leite, Lívia Brito Coelho Fontes, Alice Santos Moreira, Élder Muller Nascimento de Almeida, Claudia Ida Brodskyn, Isadora Dos Santos Lima, Washington Luís Conrado Dos Santos, Luciano Vasconcellos Pacheco, Vagner Cardoso da Silva, Jeancarlo Pereira Dos Anjos, Lílian Lefol Nani Guarieiro, Fabiana Landoni, Juliana Perrone Bezerra de Menezes, Deborah Bittencourt Mothé Fraga, Aníbal de Freitas Santos Júnior, Patrícia Sampaio Tavares Veras
Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Marcos Ferrante, Bruna Martins Macedo Leite, Lívia Brito Coelho Fontes, Alice Santos Moreira, Élder Muller Nascimento de Almeida, Claudia Ida Brodskyn, Isadora Dos Santos Lima, Washington Luís Conrado Dos Santos, Luciano Vasconcellos Pacheco, Vagner Cardoso da Silva, Jeancarlo Pereira Dos Anjos, Lílian Lefol Nani Guarieiro, Fabiana Landoni, Juliana Perrone Bezerra de Menezes, Deborah Bittencourt Mothé Fraga, Aníbal de Freitas Santos Júnior, Patrícia Sampaio Tavares Veras
Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Rubia Mitalli Tomacheuski, Marilda Onghero Taffarel, Guilherme S Cardoso, Ana A P Derussi, Marcos Ferrante, Rodrigo Volpato, Stelio Pacca Loureiro Luna
Postoperative Analgesic Effects of Laserpuncture and Meloxicam in Bitches Submitted to Ovariohysterectomy. Veterinary sciences 7 (3) (2020)